ALS Awareness Month
What is ALS Awareness Month?
In May 1992, a resolution was passed by the United States Senate to appoint May as National ALS Awareness Month, when ALS organizations and communities can unite to spread awareness regarding the disease, also called amyotrophic lateral sclerosis. At Target ALS, we recognize this time as an opportunity to share educational and inspirational content to not only the ALS community but those who are not yet familiar with ALS.
Statistics You Should Know
$250k
The estimated cost of care
for a person with ALS.
15,000
The estimated amount of U.S. ALS patients at any given time.
55-75
The average age at diagnosis is between 55 and 75 years old.
5% – 10%
Only 5% -10% of ALS cases are based on genetics.
69%
By 2040, ALS incidence rate will increase worldwide by 69%.
3 to 5 years
ALS patients typically survive 3-5 years after diagnosis.
Getting Involved in ALS Awareness Month
Join Our #WriteaNewFuture Campaign on Social Media
We’re optimistic now more than ever about achieving the innovative breakthroughs needed to end ALS, and for this year’s ALS Awareness Month, we want to inspire others to share optimism they have for their own future – whether they are a member of the ALS community, or not. Join us on Instagram Stories or Facebook Stories by downloading the background below on your phone, visiting our profile, and sharing how you’d like to #WriteaNewFuture for your personal journey. Don’t forget to tag our social handle, @targetals, in your Stories so we can follow along!
Click here to download the Stories background.
Annual Meeting
We foster ongoing networking and communication within our Target ALS Innovation Ecosystem, and are proud to host the premier ALS research meeting in the world, every year in Cambridge, Massachusetts. Nearly 350 academic and industry scientists, venture capitalists, and other investors, foundations and thought leaders attend. Learn more about this annual event, here.
Impact Takes Courage
We are proud to introduce the Target ALS Rebecca Luker Courage Award winners, presented by Mitsubishi Tanabe Pharma America, which recognizes the men and women making a difference in the fight against Amyotrophic Lateral Sclerosis (ALS).
ALS patients need your help.
With your support, we can and we will achieve breakthrough results. Finding effective treatments would finally bring new hope to patients and change the future for anyone who faces this disease. It will push us that much closer to realizing our mission: discovering a world where no one dies of ALS.
